Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell sequencing reveals increased LAMB3-positive basal keratinocytes and ZNF90-positive fibroblasts in autologous cultured epithelium. | Commun Biol | 2024 | 38200141 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation of lesional and peri-lesional skin in vitiligo: a comparative and integrated analysis of multi-omics in Chinese population. | Hum Genet | 2024 | 38182908 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. | Commun Biol | 2024 | 38182794 | PubTator, text mining | PubMed |
| ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. | Cancer Cell Int | 2024 | 38178183 | PubTator, text mining | PubMed |
| Melanogrit potentiates melanogenesis by escalating cellular tyrosinase activity and MITF levels via pERK inhibition. | Biosci Rep | 2024 | 38054639 | PubTator, text mining | PubMed |
| The molecular landscape of oculocutaneous albinism in India and its therapeutic implications. | Eur J Hum Genet | 2024 | 38030918 | PubTator, text mining | PubMed |
| Unveiling genetics of non-syndromic albinism using whole exome sequencing: A comprehensive study of TYR, TYRP1, OCA2 and MC1R genes in 17 families. | Gene | 2024 | 37956964 | PubTator, text mining | PubMed |
| Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism. | Mol Genet Genomic Med | 2024 | 37882226 | PubTator, text mining | PubMed |
| Anti-melanogenic effect of exosomes derived from human dermal fibroblasts (BJ-5ta-Ex) in C57BL/6 mice and B16F10 melanoma cells. | Pigment Cell Melanoma Res | 2024 | 37758515 | PubTator, text mining | PubMed |
Potential role of the cell-penetrating peptide-conjugated soluble N-ethylmaleimide-sensitive factor attachment protein receptor motif of vesicle-associated membrane protein 2-patterned peptide in novel cosmeceutical skin product development. | J Cosmet Dermatol | 2024 | 37698157 | PubTator, text mining | PubMed |
| Comparative Studies on the Photoreactivity, Efficacy, and Safety of Depigmenting Agents. | Pharmaceuticals (Basel) | 2023 | 38256889 | PubTator, text mining | PubMed |
| Management of the refractory vitiligo patient: current therapeutic strategies and future options. | Front Immunol | 2023 | 38239366 | PubTator, text mining | PubMed |
| Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis. | Front Pharmacol | 2023 | 38192412 | PubTator, text mining | PubMed |
| GSK3 inhibition reduces ECM production and prevents age-related macular degeneration-like pathology. | bioRxiv | 2023 | 38168310 | PubTator, text mining | PubMed |
| Comparative analysis of cysteine proteases reveals gene family evolution of the group 1 allergens in astigmatic mites. | Clin Transl Allergy | 2023 | 38146799 | PubTator, text mining | PubMed |
| Biological Activity of Fermented Plant Extracts for Potential Dermal Applications. | Pharmaceutics | 2023 | 38140115 | PubTator, text mining | PubMed |
| Exploring the Potential of Using Marine-Derived Ingredients: From the Extraction to Cutting-Edge Cosmetics. | Mar Drugs | 2023 | 38132941 | PubTator, text mining | PubMed |
| Deep-Sea Sponges and Corals off the Western Coast of Florida-Intracellular Mechanisms of Action of Bioactive Compounds and Technological Advances Supporting the Drug Discovery Pipeline. | Mar Drugs | 2023 | 38132936 | PubTator, text mining | PubMed |
| Gauging Quince Phytonutrients and Its 4% Emulgel Effect on Amplifying Facial Skin Moisturizing Potential. | Gels | 2023 | 38131920 | PubTator, text mining | PubMed |
| Monkeypox Virus Crosstalk with HIV: An Integrated Skin Transcriptome and Machine Learning Study. | ACS Omega | 2023 | 38107964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=9